ARRIVENT BIOPHARMA IN
34.19
08-November-24 15:59:57
15 minutes delayed
Stocks
-1.44
-4.04%
Today's range
33.17 - 36.37
ISIN
N/A
Source
NASDAQ
-
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
14 Aug 2024 16:01:00 By Nasdaq GlobeNewswire
-
12 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
05 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16 May 2024 16:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >